WASHINGTON, Aug 11: US drug regulators gave the nod to a wider use for Roche Holding AG’s eye drug Lucentis, approving it for diabetic patients with a vision-robbing eye condition. Lucentis, made by Roche unit Genentech, is already prescribed for two other eye ailments. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel